[CIS PIDD] [cis-pidd] FW: Immunology question

CIS-PIDD cis-pidd at lists.clinimmsoc.org
Fri Jul 22 09:28:28 EDT 2016


Dear all,

This is the protocol Novartis reached consensus with our oncology group regarding treatment with Votubia® (everolimus):
For live vaccines, Votubia® needs to be interrupted for 3-4 weeks and vaccine should be administered in the middle of this interval.
They have been doing this for the last 3 years without problems.

Best regards,


Laia Alsina, MD, PhD

Adjunta de la Secció d'Immunoal.lèrgia; Unitat Funcional d'Immunologia, Hospital Sant Joan de Déu-Hospital Clínic.
Cap d'Estudis i Presidenta de la Comisió Local de Docència de l'Hospital Sant Joan de Déu, Barcelona.
http://orcid.org/0000-0002-3559-0018



El 21 jul 2016, a las 23:43, CIS-PIDD <cis-pidd at lists.clinimmsoc.org<mailto:cis-pidd at lists.clinimmsoc.org>> escribió:

According to the green book:

https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/147824/Green-Book-Chapter-6-v2_0.pdf

patients receiving immunosuppressive drugs (e.g. azathioprine, cyclosporin, methotrexate, cyclophosphamide, leflunomide and the newer cytokine inhibitors) should not receive live vaccines until at least six months after terminating such treatment.

According to CDC:

https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/genrec.pdf

Live vaccines can be given after chemotherapy has been discontinued for at least 3 months.

Restarting immunosuppression after live viral vaccination has not been studied, but some experts would recommend at least a 1-month period.

Kind regards,
Alexandros Grammatikos

Clinical Immunology and Allergy
North Bristol NHS Trust



From: CIS-PIDD [mailto:cis-pidd at lists.clinimmsoc.org]
Sent: Thursday, July 21, 2016 10:56 PM
To: CIS-PIDD
Subject: [cis-pidd] FW: Immunology question

Colleagues:

A patient with tuberous sclerosis has been on immunosuppressant everolimus for quite some time to treat his subependymal giant cell astrocytoma.  This is a benign brain tumor that is responsive to everolimus.

The patient’s mom would like to take him off of everolimus to give him the MMR and varicella vaccines.   His neurologist says it’s OK to take him off for “a time.”

My questions:

·        How long will the immunosuppressive effect of evrolimus last, i.e. when could he receive the live virus vaccines?

·        How long after the vaccines should they wait for immune responses to “take” before restarting the everolimus?

Thank you.

Joe Church
Children’s Hospital Los Angeles




---------------------------------------------------------------------
CONFIDENTIALITY NOTICE: This e-mail message, including any attachments,
is for the sole use of the intended recipient(s) and may contain confidential
or legally privileged information. Any unauthorized review, use, disclosure
or distribution is prohibited. If you are not the intended recipient, please
contact the sender by reply e-mail and destroy all copies of this original message.

---------------------------------------------------------------------

---

You are currently subscribed to cis-pidd as: alex.grammatikos at gmail.com<mailto:alex.grammatikos at gmail.com>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396375.59e20b8565578e9e9b825111829becb6&n=T&l=cis-pidd&o=3755578

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-3755578-96396375.59e20b8565578e9e9b825111829becb6 at lyris.dundee.net<mailto:leave-3755578-96396375.59e20b8565578e9e9b825111829becb6 at lyris.dundee.net>

---

You are currently subscribed to cis-pidd as: lalsina at hsjdbcn.org<mailto:lalsina at hsjdbcn.org>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396752.60ffc8a7b421f4dafc44758305e98ac2&n=T&l=cis-pidd&o=3755692

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-3755692-96396752.60ffc8a7b421f4dafc44758305e98ac2 at lyris.dundee.net<mailto:leave-3755692-96396752.60ffc8a7b421f4dafc44758305e98ac2 at lyris.dundee.net>



---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=3756564
or send a blank email to leave-3756564-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20160722/3aa53ddc/attachment-0001.html>


More information about the PAGID mailing list